{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T11:46:27Z","timestamp":1769859987598,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T00:00:00Z","timestamp":1365984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T00:00:00Z","timestamp":1365984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2014,3,27]]},"DOI":"10.1038\/onc.2013.113","type":"journal-article","created":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T10:26:28Z","timestamp":1366021588000},"page":"1690-1699","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Glycogen synthase kinase-3\u03b2 positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1"],"prefix":"10.1038","volume":"33","author":[{"given":"S","family":"Shin","sequence":"first","affiliation":[]},{"given":"L","family":"Wolgamott","sequence":"additional","affiliation":[]},{"given":"J","family":"Tcherkezian","sequence":"additional","affiliation":[]},{"given":"S","family":"Vallabhapurapu","sequence":"additional","affiliation":[]},{"given":"Y","family":"Yu","sequence":"additional","affiliation":[]},{"given":"P P","family":"Roux","sequence":"additional","affiliation":[]},{"given":"S-O","family":"Yoon","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,4,15]]},"reference":[{"issue":"Suppl 1","key":"BFonc2013113_CR1","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.diabres.2007.01.033","volume":"77","author":"J Lee","year":"2007","unstructured":"Lee J, Kim MS . The role of GSK3 in glucose homeostasis and the development of insulin resistance. Diabetes Res Clin Pract 2007; 77 (Suppl 1): S49\u2013S57.","journal-title":"Diabetes Res Clin Pract"},{"key":"BFonc2013113_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nrn2870","volume":"11","author":"EM Hur","year":"2010","unstructured":"Hur EM, Zhou FQ . GSK3 signalling in neural development. Nat Rev Neurosci 2010; 11: 539\u2013551.","journal-title":"Nat Rev Neurosci"},{"key":"BFonc2013113_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.canlet.2008.05.045","volume":"273","author":"J Luo","year":"2009","unstructured":"Luo J . Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett 2009; 273: 194\u2013200.","journal-title":"Cancer Lett"},{"key":"BFonc2013113_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ccr.2008.10.013","volume":"14","author":"S Patel","year":"2008","unstructured":"Patel S, Woodgett J . Glycogen synthase kinase-3 and cancer: good cop, bad cop? Cancer Cell 2008; 14: 351\u2013353.","journal-title":"Cancer Cell"},{"key":"BFonc2013113_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0065-230X(02)84007-6","volume":"84","author":"AS Manoukian","year":"2002","unstructured":"Manoukian AS, Woodgett JR . Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways. Adv Cancer Res 2002; 84: 203\u2013229.","journal-title":"Adv Cancer Res"},{"key":"BFonc2013113_CR6","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.2174\/187152009789734982","volume":"9","author":"K Miyashita","year":"2009","unstructured":"Miyashita K, Nakada M, Shakoori A, Ishigaki Y, Shimasaki T, Motoo Y et al. An emerging strategy for cancer treatment targeting aberrant glycogen synthase kinase 3beta. Anticancer Agents Med Chem 2009; 9: 1114\u20131122.","journal-title":"Anticancer Agents Med Chem"},{"key":"BFonc2013113_CR7","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ccr.2010.04.024","volume":"17","author":"Z Wang","year":"2010","unstructured":"Wang Z, Iwasaki M, Ficara F, Lin C, Matheny C, Wong SH et al. GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesis. Cancer Cell 2010; 17: 597\u2013608.","journal-title":"Cancer Cell"},{"key":"BFonc2013113_CR8","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/nature07284","volume":"455","author":"Z Wang","year":"2008","unstructured":"Wang Z, Smith KS, Murphy M, Piloto O, Somervaille TC, Cleary ML . Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy. Nature 2008; 455: 1205\u20131209.","journal-title":"Nature"},{"key":"BFonc2013113_CR9","doi-asserted-by":"publisher","first-page":"E1204","DOI":"10.1073\/pnas.1110195108","volume":"108","author":"S Shin","year":"2011","unstructured":"Shin S, Wolgamott L, Yu Y, Blenis J, Yoon SO . Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation. Proc Natl Acad Sci USA 2011; 108: E1204\u2013E1213.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013113_CR10","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2006-12-060947","volume":"110","author":"AV Ougolkov","year":"2007","unstructured":"Ougolkov AV, Bone ND, Fernandez-Zapico ME, Kay NE, Billadeau DD . Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells. Blood 2007; 110: 735\u2013742.","journal-title":"Blood"},{"key":"BFonc2013113_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/35017574","volume":"406","author":"KP Hoeflich","year":"2000","unstructured":"Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR . Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 2000; 406: 86\u201390.","journal-title":"Nature"},{"key":"BFonc2013113_CR12","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S0960-9822(02)00888-6","volume":"12","author":"DR Foltz","year":"2002","unstructured":"Foltz DR, Santiago MC, Berechid BE, Nye JS . Glycogen synthase kinase-3beta modulates notch signaling and stability. Curr Biol 2002; 12: 1006\u20131011.","journal-title":"Curr Biol"},{"key":"BFonc2013113_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1101\/gad.1165804","volume":"18","author":"L Qu","year":"2004","unstructured":"Qu L, Huang S, Baltzis D, Rivas-Estilla AM, Pluquet O, Hatzoglou M et al. Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3beta. Genes Dev 2004; 18: 261\u2013277.","journal-title":"Genes Dev"},{"key":"BFonc2013113_CR14","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.molcel.2007.11.009","volume":"28","author":"N Rocques","year":"2007","unstructured":"Rocques N, Abou Zeid N, Sii-Felice K, Lecoin L, Felder-Schmittbuhl MP, Eychene A et al. GSK-3-mediated phosphorylation enhances Maf-transforming activity. Mol Cell 2007; 28: 584\u2013597.","journal-title":"Mol Cell"},{"key":"BFonc2013113_CR15","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1038\/onc.2011.164","volume":"30","author":"Y Lu","year":"2011","unstructured":"Lu Y, Muller M, Smith D, Dutta B, Komurov K, Iadevaia S et al. Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling. Oncogene 2011; 30: 4567\u20134577.","journal-title":"Oncogene"},{"key":"BFonc2013113_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2217\/14796694.2.1.91","volume":"2","author":"AV Ougolkov","year":"2006","unstructured":"Ougolkov AV, Billadeau DD . Targeting GSK-3: a promising approach for cancer therapy? Future Oncol 2006; 2: 91\u2013100.","journal-title":"Future Oncol"},{"key":"BFonc2013113_CR17","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1158\/1535-7163.MCT-10-0925","volume":"10","author":"T Liu","year":"2011","unstructured":"Liu T, Yacoub R, Taliaferro-Smith LD, Sun SY, Graham TR, Dolan R et al. Combinatorial effects of lapatinib and rapamycin in triple-negative breast cancer cells. Mol Cancer Ther 2011; 10: 1460\u20131469.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2013113_CR18","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.ejca.2010.01.014","volume":"46","author":"Q Zeng","year":"2010","unstructured":"Zeng Q, Yang Z, Gao YJ, Yuan H, Cui K, Shi Y et al. Treating triple-negative breast cancer by a combination of rapamycin and cyclophosphamide: an in vivo bioluminescence imaging study. Eur J Cancer 2010; 46: 1132\u20131143.","journal-title":"Eur J Cancer"},{"key":"BFonc2013113_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nrclinonc.2011.16","volume":"8","author":"SP Blagden","year":"2011","unstructured":"Blagden SP, Willis AE . The biological and therapeutic relevance of mRNA translation in cancer. Nat Rev Clin Oncol 2011; 8: 280\u2013291.","journal-title":"Nat Rev Clin Oncol"},{"key":"BFonc2013113_CR20","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1038\/emboj.2008.228","volume":"27","author":"MA Mir","year":"2008","unstructured":"Mir MA, Panganiban AT . A protein that replaces the entire cellular eIF4F complex. EMBO J 2008; 27: 3129\u20133139.","journal-title":"EMBO J"},{"key":"BFonc2013113_CR21","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1101\/gad.13.11.1422","volume":"13","author":"AC Gingras","year":"1999","unstructured":"Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF et al. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev 1999; 13: 1422\u20131437.","journal-title":"Genes Dev"},{"key":"BFonc2013113_CR22","doi-asserted-by":"publisher","first-page":"34355","DOI":"10.1074\/jbc.M110.135103","volume":"285","author":"MI Ayuso","year":"2010","unstructured":"Ayuso MI, Hernandez-Jimenez M, Martin ME, Salinas M, Alcazar A . New hierarchical phosphorylation pathway of the translational repressor eIF4E-binding protein 1 (4E-BP1) in ischemia-reperfusion stress. J Biol Chem 2010; 285: 34355\u201334363.","journal-title":"J Biol Chem"},{"key":"BFonc2013113_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0076-6879(07)31007-0","volume":"431","author":"X Wang","year":"2007","unstructured":"Wang X, Proud CG . Methods for studying signal-dependent regulation of translation factor activity. Methods Enzymol 2007; 431: 113\u2013142.","journal-title":"Methods Enzymol"},{"key":"BFonc2013113_CR24","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1101\/gad.887201","volume":"15","author":"AC Gingras","year":"2001","unstructured":"Gingras AC, Raught B, Gygi SP, Niedzwiecka A, Miron M, Burley SK et al. Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev 2001; 15: 2852\u20132864.","journal-title":"Genes Dev"},{"key":"BFonc2013113_CR25","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1128\/MCB.23.5.1546-1557.2003","volume":"23","author":"X Wang","year":"2003","unstructured":"Wang X, Li W, Parra JL, Beugnet A, Proud CG . The C terminus of initiation factor 4E-binding protein 1 contains multiple regulatory features that influence its function and phosphorylation. Mol Cell Biol 2003; 23: 1546\u20131557.","journal-title":"Mol Cell Biol"},{"key":"BFonc2013113_CR26","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.4161\/cc.10.18.17321","volume":"10","author":"JW Tullai","year":"2011","unstructured":"Tullai JW, Graham JR, Cooper GM . A GSK-3-mediated transcriptional network maintains repression of immediate early genes in quiescent cells. Cell Cycle 2011; 10: 3072\u20133077.","journal-title":"Cell Cycle"},{"key":"BFonc2013113_CR27","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1161\/01.RES.0000018952.70505.F1","volume":"90","author":"SE Hardt","year":"2002","unstructured":"Hardt SE, Sadoshima J . Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circ Res 2002; 90: 1055\u20131063.","journal-title":"Circ Res"},{"key":"BFonc2013113_CR28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S1471-4914(01)02266-3","volume":"8","author":"H Eldar-Finkelman","year":"2002","unstructured":"Eldar-Finkelman H . Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol Med 2002; 8: 126\u2013132.","journal-title":"Trends Mol Med"},{"key":"BFonc2013113_CR29","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1242\/jcs.00384","volume":"116","author":"BW Doble","year":"2003","unstructured":"Doble BW, Woodgett JR . GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 2003; 116: 1175\u20131186.","journal-title":"J Cell Sci"},{"key":"BFonc2013113_CR30","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1126\/science.1199484","volume":"332","author":"Y Yu","year":"2011","unstructured":"Yu Y, Yoon SO, Poulogiannis G, Yang Q, Ma XM, Villen J et al. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 2011; 332: 1322\u20131326.","journal-title":"Science"},{"key":"BFonc2013113_CR31","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1084\/jem.20111855","volume":"208","author":"C Lobry","year":"2011","unstructured":"Lobry C, Oh P, Aifantis I . Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think. J Exp Med 2011; 208: 1931\u20131935.","journal-title":"J Exp Med"},{"key":"BFonc2013113_CR32","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S1470-2045(11)70041-9","volume":"12","author":"R Tabares-Seisdedos","year":"2011","unstructured":"Tabares-Seisdedos R, Dumont N, Baudot A, Valderas JM, Climent J, Valencia A et al. No paradox, no progress: inverse cancer comorbidity in people with other complex diseases. Lancet Oncol 2011; 12: 604\u2013608.","journal-title":"Lancet Oncol"},{"key":"BFonc2013113_CR33","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1001\/jama.2008.824","volume":"300","author":"BB Barone","year":"2008","unstructured":"Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 2008; 300: 2754\u20132764.","journal-title":"JAMA"},{"key":"BFonc2013113_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1470-2045(05)01736-5","volume":"6","author":"I Wolf","year":"2005","unstructured":"Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B . Diabetes mellitus and breast cancer. Lancet Oncol 2005; 6: 103\u2013111.","journal-title":"Lancet Oncol"},{"key":"BFonc2013113_CR35","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ccr.2010.05.017","volume":"17","author":"NW Birch","year":"2010","unstructured":"Birch NW, Zeleznik-Le NJ . Glycogen synthase kinase-3 and leukemia: restoring the balance. Cancer Cell 2010; 17: 529\u2013531.","journal-title":"Cancer Cell"},{"key":"BFonc2013113_CR36","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nature02866","volume":"431","author":"SH Um","year":"2004","unstructured":"Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 2004; 431: 200\u2013205.","journal-title":"Nature"},{"key":"BFonc2013113_CR37","doi-asserted-by":"publisher","first-page":"10943","DOI":"10.1074\/jbc.M007758200","volume":"276","author":"YP Jiang","year":"2001","unstructured":"Jiang YP, Ballou LM, Lin RZ . Rapamycin-insensitive regulation of 4e-BP1 in regenerating rat liver. J Biol Chem 2001; 276: 10943\u201310951.","journal-title":"J Biol Chem"},{"key":"BFonc2013113_CR38","doi-asserted-by":"publisher","first-page":"17414","DOI":"10.1073\/pnas.0809136105","volume":"105","author":"AY Choo","year":"2008","unstructured":"Choo AY, Yoon SO, Kim SG, Roux PP, Blenis J . Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc Natl Acad Sci USA 2008; 105: 17414\u201317419.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013113_CR39","doi-asserted-by":"publisher","first-page":"594","DOI":"10.4161\/cc.11.3.19096","volume":"11","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Zheng XF . mTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors. Cell Cycle 2012; 11: 594\u2013603.","journal-title":"Cell Cycle"},{"key":"BFonc2013113_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ccr.2010.01.021","volume":"17","author":"AC Hsieh","year":"2010","unstructured":"Hsieh AC, Costa M, Zollo O, Davis C, Feldman ME, Testa JR et al. Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. Cancer Cell 2010; 17: 249\u2013261.","journal-title":"Cancer Cell"},{"key":"BFonc2013113_CR41","doi-asserted-by":"publisher","first-page":"rs8","DOI":"10.1126\/scisignal.2001699","volume":"4","author":"A Vinayagam","year":"2011","unstructured":"Vinayagam A, Stelzl U, Foulle R, Plassmann S, Zenkner M, Timm J et al. A directed protein interaction network for investigating intracellular signal transduction. Sci Signal 2011; 4: rs8.","journal-title":"Sci Signal"},{"key":"BFonc2013113_CR42","doi-asserted-by":"publisher","first-page":"pe27","DOI":"10.1126\/scisignal.267pe27","volume":"2","author":"DR Alessi","year":"2009","unstructured":"Alessi DR, Pearce LR, Garcia-Martinez JM . New insights into mTOR signaling: mTORC2 and beyond. Sci Signal 2009; 2: pe27.","journal-title":"Sci Signal"},{"key":"BFonc2013113_CR43","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ceb.2009.10.007","volume":"22","author":"A Efeyan","year":"2010","unstructured":"Efeyan A, Sabatini DM . mTOR and cancer: many loops in one pathway. Curr Opin Cell Biol 2010; 22: 169\u2013176.","journal-title":"Curr Opin Cell Biol"},{"key":"BFonc2013113_CR44","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1038\/sj.onc.1205662","volume":"21","author":"LE Horton","year":"2002","unstructured":"Horton LE, Bushell M, Barth-Baus D, Tilleray VJ, Clemens MJ, Hensold JO . p53 activation results in rapid dephosphorylation of the eIF4E-binding protein 4E-BP1, inhibition of ribosomal protein S6 kinase and inhibition of translation initiation. Oncogene 2002; 21: 5325\u20135334.","journal-title":"Oncogene"},{"key":"BFonc2013113_CR45","doi-asserted-by":"publisher","first-page":"7170","DOI":"10.1128\/MCB.25.16.7170-7180.2005","volume":"25","author":"R Kulikov","year":"2005","unstructured":"Kulikov R, Boehme KA, Blattner C . Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance. Mol Cell Biol 2005; 25: 7170\u20137180.","journal-title":"Mol Cell Biol"},{"key":"BFonc2013113_CR46","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1038\/emboj.2010.271","volume":"29","author":"WJ Oh","year":"2010","unstructured":"Oh WJ, Wu CC, Kim SJ, Facchinetti V, Julien LA, Finlan M et al. mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide. EMBO J 2010; 29: 3939\u20133951.","journal-title":"EMBO J"},{"key":"BFonc2013113_CR47","doi-asserted-by":"publisher","first-page":"23552","DOI":"10.1074\/jbc.M111.258004","volume":"286","author":"MM Keshwani","year":"2011","unstructured":"Keshwani MM, von Daake S, Newton AC, Harris TK, Taylor SS . Hydrophobic motif phosphorylation is not required for activation loop phosphorylation of p70 ribosomal protein S6 kinase 1 (S6K1). J Biol Chem 2011; 286: 23552\u201323558.","journal-title":"J Biol Chem"},{"key":"BFonc2013113_CR48","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/978-0-387-69252-4_37","volume-title":"Pancreatic Cancer","author":"GP Kim","year":"2008","unstructured":"Kim GP, Billadeau DD . GSK-3\u03b2 inhibition in pancreatic cancer. In: Lowy AM, Leach SD, Philip PA, (eds). Pancreatic Cancer. Springer, US,, 2008, pp 635\u2013646."},{"key":"BFonc2013113_CR49","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1158\/0008-5472.CAN-04-3642","volume":"65","author":"AV Ougolkov","year":"2005","unstructured":"Ougolkov AV, Fernandez-Zapico ME, Savoy DN, Urrutia RA, Billadeau DD . Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res 2005; 65: 2076\u20132081.","journal-title":"Cancer Res"},{"key":"BFonc2013113_CR50","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1476-4598-9-144","volume":"9","author":"R Mishra","year":"2010","unstructured":"Mishra R . Glycogen synthase kinase 3 beta: can it be a target for oral cancer. Mol Cancer 2010; 9: 144.","journal-title":"Mol Cancer"},{"key":"BFonc2013113_CR51","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.bbrc.2005.07.041","volume":"334","author":"A Shakoori","year":"2005","unstructured":"Shakoori A, Ougolkov A, Yu ZW, Zhang B, Modarressi MH, Billadeau DD et al. Deregulated GSK3beta activity in colorectal cancer: its association with tumor cell survival and proliferation. Biochem Biophys Res Commun 2005; 334: 1365\u20131373.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2013113_CR52","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.molcel.2010.02.020","volume":"38","author":"S Shin","year":"2010","unstructured":"Shin S, Dimitri CA, Yoon SO, Dowdle W, Blenis J . ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events. Mol Cell 2010; 38: 114\u2013127.","journal-title":"Mol Cell"},{"key":"BFonc2013113_CR53","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ccr.2006.10.008","volume":"10","author":"RM Neve","year":"2006","unstructured":"Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006; 10: 515\u2013527.","journal-title":"Cancer Cell"},{"key":"BFonc2013113_CR54","doi-asserted-by":"publisher","first-page":"14056","DOI":"10.1074\/jbc.M700906200","volume":"282","author":"PP Roux","year":"2007","unstructured":"Roux PP, Shahbazian D, Vu H, Holz MK, Cohen MS, Taunton J et al. RAS\/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation. J Biol Chem 2007; 282: 14056\u201314064.","journal-title":"J Biol Chem"},{"key":"BFonc2013113_CR55","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1139\/Y10-010","volume":"88","author":"Y Chen","year":"2010","unstructured":"Chen Y, Azad MB, Gibson SB . Methods for detecting autophagy and determining autophagy-induced cell death. Can J Physiol Pharmacol 2010; 88: 285\u2013295.","journal-title":"Can J Physiol Pharmacol"},{"key":"BFonc2013113_CR56","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1111\/j.1349-7006.2007.00545.x","volume":"98","author":"A Shakoori","year":"2007","unstructured":"Shakoori A, Mai W, Miyashita K, Yasumoto K, Takahashi Y, Ooi A et al. Inhibition of GSK-3 beta activity attenuates proliferation of human colon cancer cells in rodents. Cancer Sci 2007; 98: 1388\u20131393.","journal-title":"Cancer Sci"},{"key":"BFonc2013113_CR57","doi-asserted-by":"publisher","first-page":"6810","DOI":"10.1158\/1078-0432.CCR-09-0973","volume":"15","author":"W Mai","year":"2009","unstructured":"Mai W, Kawakami K, Shakoori A, Kyo S, Miyashita K, Yokoi K et al. Deregulated GSK3(beta) sustains gastrointestinal cancer cells survival by modulating human telomerase reverse transcriptase and telomerase. Clin Cancer Res 2009; 15: 6810\u20136819.","journal-title":"Clin Cancer Res"},{"key":"BFonc2013113_CR58","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0076-6879(08)03611-2","volume":"452","author":"T Ikenoue","year":"2009","unstructured":"Ikenoue T, Hong S, Inoki K . Monitoring mammalian target of rapamycin (mTOR) activity. Methods Enzymol 2009; 452: 165\u2013180.","journal-title":"Methods Enzymol"},{"key":"BFonc2013113_CR59","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.molonc.2007.02.004","volume":"1","author":"PA Kenny","year":"2007","unstructured":"Kenny PA, Lee GY, Myers CA, Neve RM, Semeiks JR, Spellman PT et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol 2007; 1: 84\u201396.","journal-title":"Mol Oncol"},{"key":"BFonc2013113_CR60","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth1015","volume":"4","author":"GY Lee","year":"2007","unstructured":"Lee GY, Kenny PA, Lee EH, Bissell MJ . Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 2007; 4: 359\u2013365.","journal-title":"Nat Methods"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2013113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013113","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:16:45Z","timestamp":1647890205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2013113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,15]]},"references-count":60,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2014,3,27]]}},"alternative-id":["BFonc2013113"],"URL":"https:\/\/doi.org\/10.1038\/onc.2013.113","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,15]]},"assertion":[{"value":"20 August 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}